Education Research Current About VU Amsterdam NL
Login as
Prospective student Student Employee
Bachelor Master VU for Professionals
Exchange programme VU Amsterdam Summer School Honours programme VU-NT2 Semester in Amsterdam
PhD at VU Amsterdam Research highlights Prizes and distinctions
Research institutes Our scientists Research Impact Support Portal Creating impact
News Events calendar Biodiversity at VU Amsterdam
Israël and Palestinian regions Culture on campus
Practical matters Mission and core values Entrepreneurship on VU Campus
Governance Partnerships Alumni University Library Working at VU Amsterdam
Sorry! De informatie die je zoekt, is enkel beschikbaar in het Engels.
This programme is saved in My Study Choice.
Something went wrong with processing the request.
Something went wrong with processing the request.

Create new medicines from a chemical perspective

This two-year Master’s programme equips you with the knowledge and skills to tackle today’s challenges in drug discovery through three research specialisations: Design and Synthesis, Pharmacology and Toxicology, or Bioanalytics. Each specialisation combines compulsory courses, elective modules and research training, giving you the flexibility to shape your own expertise.

Choose your own research flavour
Work in a multidisciplinary environment and tackle key questions about future medicines while specialising in Design and Synthesis, Pharmacology and Toxicology or Bioanalytics. Explore which specialisation best fits your interests in the detailed descriptions below.

Research project
The major research project is the key component of your programme. You will develop expertise in a specific research topic, such as drug synthesis, nanobody development, cellular toxicology, protein-ligand interaction studies, or advanced bioanalytical methods.

Educational specialisation
If you are interested in teaching at Dutch pre-university or vocational education level, this specialisation will be the right choice. In the first year you follow Drug Discovery Sciences courses and perform a short in silico research internship, and in the second year you complete the Dutch teacher training programme to obtain a teaching certificate in secondary education.

Study guide
You can find all course descriptions, the year schedule and the teaching and examination regulations in the Study guide.

The start date of this programme is 1 September. 

VU Master's Event

Saturday 7 March 2026

Which specialisation do you choose?

Find out what the different possibilities are within the first year of this Master's programme

Summary

Making biologically active molecules come to life
The Design and Synthesis in Drug Discovery (DSDD) specialisation within the Drug Discovery Sciences Master’s programme focuses on the design and synthesis of biologically active molecules.

This specialisation offers two complementary exciting chemistry-based paths:

  • Synthetic Medicinal Chemistry: this path focuses on the use of organic chemistry in a broader interdisciplinary drug and chemical biology setting. Students gain expertise in the organic chemistry of drug-like compounds, biocatalysis, radiolabelled molecules, and advanced synthetic methodologies. Students also receive extensive hands-on training with cutting-edge technologies for synthesis planning, compound synthesis, purification, and structural characterisation, preparing them for roles in chemical research in academic, company or institute settings alike. This path in the DSDD specialisation is ideal for students passionate about organic chemistry and its critical role in drug discovery, diagnostics, and life sciences. 

     Click here for a personal video made by Specialisation Coordinator Maikel Wijtmans, in which he shares his  
     passion for synthetic medicinal chemistry and gives you an inside look into the VU synthesis laboratories.

  • Computer-Aided Drug Design: this path focuses on leveraging molecular modelling and computational (bio)chemistry techniques to understand the biomolecular basis of drug action. Students will explore state-of-the-art methodologies, such as pharmacophore modelling, molecular docking, and molecular dynamics simulations, to rationally design next-generation drug compounds and predict their interactions. This path in the DSDD specialisation is ideal for students eager to apply cutting-edge computational techniques to improve drug discovery, enhance drug efficacy, and prevent unwanted side effects, with a strong emphasis on interdisciplinary collaboration in drug design and development.

     Click here for a video on the exciting aspects of computer-aided drug design, with an inside look into the   
     VU modeling laboratories.

Curriculum
The study programme of this specialisation consists of compulsory courses (12 ECTS), constrained elective courses (at least 12 ECTS), additional elective modules, and a major research project (48 ECTS), conducted in either an academic, company or institute setting.

The compulsory courses within the DSDD specialisation cover:

  • Physical Organic Chemistry: focusing on the physical-chemistry concepts that are essential for both understanding and exercising organic synthesis as well as for understanding drug-ligand interaction.
  • Computational Design and Synthesis of Drugs: focusing on the use of molecular modelling and retrosynthetic analysis to discover molecular hits for drug research.

The compulsory courses are complemented by the selection of at least two out of six constrained electives that are chosen depending on the path taken within this specialisation. The constrained elective courses include:

  • Synthetic Approaches in Medicinal Chemistry: covering the toolbox of synthetic-organic reactions that drug researchers have at their disposal to prepare biologically interesting organic molecules.
  • Computer-Aided Drug Design and Virtual Screening: exploring key concepts in protein homology modelling, chemoinformatics, and structure-based virtual screening, with a focus on ligand discovery, molecular docking, and integrating in silico methods with experimental studies.
  • Spectroscopic Approaches in Medicinal Chemistry: exploring various techniques key in safeguarding the identity and purity of synthesised molecules, with an emphasis on advanced 2D NMR spectroscopy.
  • Data Analysis in Drug Discovery: learning how to efficiently retrieve, manage, and analyse research data from drug discovery using databases and open-source tools, with a focus on automating data tasks, applying advanced analysis techniques (including AI) and developing robust data management plans.
  • Biocatalysis for a Sustainable Future: exploring the use of enzymes to facilitate smart and sustainable organic synthesis, as inspired by the biocatalytic mechanisms in nature.
  • Advanced Radiopharmaceutical Chemistry: learning how to chemically synthesise and use molecules that incorporate short-lived isotopes for use in clinical diagnostics.

Depending on the interest of the student, courses addressing both paths can be selected as electives to become more interdisciplinary trained within the design and synthesis of drugs.

In addition to the compulsory courses and constrained electives, students may choose from further electives, such as additional courses, a literature thesis, or a minor research project, enabling them to broaden their profile and strengthen their interdisciplinary training.

If you have any questions about the curriculum, please visit the Online Master’s Event on 27 November or contact the specialisation coordinator.

Ideal candidates
The DSDD specialisation is designed for students with a background in organic and physical chemistry and with a keen interest in understanding and exploring the role of chemistry in drug research, chemical biology, and diagnosis. The following background per path in this specialisation is expected:

  • Synthetic Medicinal Chemistry path: the candidate has a background in organic synthesis and/or synthetic medicinal chemistry, as evidenced by theoretical courses, practical courses and research internship(s).
  • Computer-Aided Drug Design path: the candidate has a background in molecular modelling and/or physical chemistry, as evidenced by theoretical courses, practical courses and research internship(s).

Learn more about admission requirements.

Summary

Unravelling the molecular mechanisms behind drug action and their harmful side effects
The Pharmacology and Toxicology in Drug Discovery (PTDD) specialisation within the Drug Discovery Sciences Master’s programme focuses on the beneficial and adverse effects of drugs on biological systems at the molecular and cellular levels.

This specialisation offers two complementary paths:

  • Molecular Pharmacology: this path focuses on the intricate mechanisms by which drugs interact with biological systems at the molecular and cellular levels. This track equips students with a profound understanding of receptor pharmacology, signal transduction pathways, and the molecular basis of drug efficacy. Emphasising both theoretical knowledge and practical skills, the programme prepares graduates to contribute to the development of novel therapeutics and the optimization of existing drug therapies.
  • Molecular Toxicology: this path focuses on the in-depth exploration of the cellular stress responses and the molecular mechanisms underlying the toxic effects of pharmaceuticals, as well as food additives, contaminants, environmental pollutants, and industrial chemicals. This track equips students with the knowledge and skills to assess and predict toxicological outcomes, contributing to the development of safer therapeutic agents and protection of public health. By integrating theoretical knowledge with practical experience, the programme prepares graduates to address complex challenges in toxicology and health sciences.

     Click here for a video where VU scientist Anja Wilmes is investigating possibilities to make medicines more
     personal, so that they better match the DNA of your body. 

Curriculum
The study programme of this specialisation consists of compulsory courses (12 ECTS), constrained elective courses (at least 12 ECTS), additional elective modules, and a major research project (48 ECTS), conducted in an academic, company or institute setting.

The compulsory courses within the PTDD specialisation cover:

  • ADME: understanding how absorption, distribution, metabolism, and excretion influence drug efficacy and safety.
  • Drug Target Biochemistry and Signalling: exploring the pathways and networks involved in cellular responses to drugs.

The compulsory courses are complemented by the selection of at least two out of six constrained electives, selected according to the chosen path. The constrained elective courses include:

  • Advanced pharmacology: focusing on the molecular basis and quantification of drug-target interaction and modulation of cellular responses.
  • Molecular and Cellular Toxicology: understanding of the major stress-response pathways and methods to study the effect of chemicals/drugs on cells.
  • Advanced Bioanalytical Approaches: mastering state-of-the-art techniques for bioanalysis, from sample preparation to data interpretation, in drug discovery, clinical, toxicological, and forensic contexts.
  • Biopharmaceutical and Biopharma Proteomics: understanding the development, characterization, and bioanalytical techniques for biopharmaceuticals, with a focus on monoclonal antibodies, venoms-to-drugs pipelines, and proteomics in drug discovery.
  • Advanced Course in Molecular Toxicology: an in-depth exploration of toxicological principles, mechanisms of toxicity, and current research topics in molecular toxicology.
  • Data Analysis in Drug Discovery: learning how to efficiently retrieve, manage, and analyse research data from drug discovery using databases and open-source tools, with focuses on automating data tasks, applying advanced analysis techniques (including AI) and developing robust data management plans.

Depending on the student’s interests, courses from both paths can be selected as electives to become interdisciplinarily trained in the field of pharmacology and toxicology.

If you have any questions about the curriculum, please visit the Online Master’s Event on 27 November or contact the specialisation coordinator.

Ideal candidates
This specialisation is designed for students with a BSc or BASc background in medicinal chemistry, biochemistry, pharmacology, molecular biology, cellular biology, or related fields, and a keen interest in understanding the molecular basis of drug actions and/or toxicity. A commitment to scientific research and a passion for innovation in therapeutic discovery and development, and/or improving public health through the study of toxicology are essential qualities for prospective students.

Learn more about admission requirements.

Summary

Unravelling molecular insights in drug discovery
The Bioanalytics in Drug Discovery (BADD) specialisation within the Master’s programme in Drug Discovery Sciences focuses on advanced analytical techniques central to modern drug discovery and development. Students gain expertise in state-of-the-art methods, including mass spectrometry, chromatography, and nuclear magnetic resonance spectroscopy, to investigate drug candidates, their metabolites, their interactions with protein-based targets, and the molecular mechanisms underpinning therapeutic interventions. This specialisation is designed for students eager to apply cutting-edge bioanalytical tools to improve drug efficacy, deepen their understanding of disease mechanisms, and contribute to the creation of safer, more effective therapies. Students also receive dedicated training in metabolomics and proteomics. With a strong emphasis on practical experience and interdisciplinary collaboration, the programme equips graduates for impactful careers in pharmaceutical research, biotechnology, and any other career avenues involving bioanalytical chemistry expertise.

Click here for a video about what you can learn during the Bioanalytics specialisation.

Curriculum
The study programme of this specialisation consists of compulsory courses (12 ECTS), constrained elective courses (at least 12 ECTS), additional elective modules, and a major research project (48 ECTS), conducted in either an academic, a company or an institute setting in the Netherlands or abroad.

The compulsory courses within the BADD specialisation cover:

  • Advanced Bioanalytical Approaches: mastering state-of-the-art techniques for bioanalysis, from sample preparation to data interpretation, in drug discovery, clinical, toxicological, and forensic contexts.
  • Biopharmaceuticals & Biopharma Proteomics: understanding the development, characterisation, and bioanalytical techniques for biopharmaceuticals, with a focus on monoclonal antibodies, venoms-to-drugs pipelines, and proteomics in drug discovery.

The compulsory courses are complemented by the selection of minimally two out of six constrained electives. The constrained elective courses include:

  • ADME: understanding how absorption, distribution, metabolism, and excretion influence drug efficacy and safety.
  • Drug Target Biochemistry and Signalling: exploring the pathways and networks involved in cellular responses to drugs.
  • Spectroscopic Approaches in Medicinal Chemistry: exploring various techniques key to safeguarding the identity and purity of synthesised molecules, with an emphasis on advanced 2D NMR spectroscopy.
  • Separation Sciences: exploring the fundamentals and applications of chromatography and electrophoresis, including topics such as instrumentation, sample preparation, separation performance, gradient elution, two-dimensional gas chromatography, and polymer analysis.
  • Biocatalysis for a Sustainable Future: exploring the use of enzymes to facilitate smart and sustainable organic synthesis, as inspired by the biocatalytic mechanisms in nature.
  • Data Analysis in Drug Discovery: learning how to efficiently retrieve, manage, and analyse research data from drug discovery using databases and open-source tools, with a focus on automating data tasks, applying advanced analysis techniques (including AI) and developing robust data management plans.

In addition to the compulsory courses and constrained electives, students may choose from further electives, such as additional courses, a literature thesis, or a minor research project, enabling them to broaden their profile and strengthen their interdisciplinary training.

If you have any questions about the curriculum, please visit the Online Master’s Event on 27 November or contact the specialisation coordinator.

Ideal candidates
The BADD specialisation is designed for students with a background in analytical chemistry, as evidenced by theoretical courses, practical courses, and preferably a research internship in the field. They also have a strong interest in applying analytical techniques to investigate drug action and disease mechanisms.

Learn more about admission requirements.

Summary

From lab to classroom
The Educational specialisation within the Drug Discovery Sciences Master’s programme is designed for those who want to pursue a teaching career. The programme starts with a first year consisting of courses in drug discovery sciences and a research internship. In the second year, students follow the Dutch teacher training program, which leads to a qualification to teach at secondary and vocational education levels. Please note that the second year of this track is taught in Dutch.

Curriculum
The Educational specialisation offers a tightly structured programme: the first year focuses on building subject-specific expertise in drug discovery sciences, while the second year is dedicated to applying this knowledge in teaching practice.

Year 1: Drug Discovery Sciences

This year covers:

  • Compulsory DDS courses (12 ECTS):
    • ADME: understanding how absorption, distribution, metabolism, and excretion influence drug efficacy and safety.
    • Computational Design and Synthesis of Drugs: focusing on the use of molecular modelling and retrosynthetic analysis to discover molecular hits for drug research.
  • Elective modules (18 ECTS): within this component, you choose courses based on your interests and the topic of your research internship. We strongly recommend the course Computer-Aided Drug Design and Virtual Screening (6 ECTS). Please note that if you have not completed the bachelor’s programme in Pharmaceutical Sciences at VU, you are required to take two additional Principles courses (12 ECTS) within this component.
  • Research internship (30 ECTS): usually running from February to July. The education major project primarily focused on modelling, dry lab internships and in silico experiments. Contact the specialisation coordinator for more information about possible projects.

Year 2: Teacher education covers:

Because of the strict planning, courses from the first year cannot be shifted into the second year. The specialisation coordinator will guide you in planning your first year, while a dedicated education coordinator will support you during the second year.

For detailed information about the individual courses, please see the Study Guide.

Ideal candidate
The Educational specialisation is intended for students with a strong background in (bio)chemistry who are eager to share their knowledge with the next generation. It is the right choice for those who want to combine their expertise in drug discovery sciences with pedagogy and obtain a formal qualification to teach chemistry at Dutch secondary and vocational education level.

  • Design and Synthesis in Drug Discovery

    Summary

    Making biologically active molecules come to life
    The Design and Synthesis in Drug Discovery (DSDD) specialisation within the Drug Discovery Sciences Master’s programme focuses on the design and synthesis of biologically active molecules.

    This specialisation offers two complementary exciting chemistry-based paths:

    • Synthetic Medicinal Chemistry: this path focuses on the use of organic chemistry in a broader interdisciplinary drug and chemical biology setting. Students gain expertise in the organic chemistry of drug-like compounds, biocatalysis, radiolabelled molecules, and advanced synthetic methodologies. Students also receive extensive hands-on training with cutting-edge technologies for synthesis planning, compound synthesis, purification, and structural characterisation, preparing them for roles in chemical research in academic, company or institute settings alike. This path in the DSDD specialisation is ideal for students passionate about organic chemistry and its critical role in drug discovery, diagnostics, and life sciences. 

         Click here for a personal video made by Specialisation Coordinator Maikel Wijtmans, in which he shares his  
         passion for synthetic medicinal chemistry and gives you an inside look into the VU synthesis laboratories.

    • Computer-Aided Drug Design: this path focuses on leveraging molecular modelling and computational (bio)chemistry techniques to understand the biomolecular basis of drug action. Students will explore state-of-the-art methodologies, such as pharmacophore modelling, molecular docking, and molecular dynamics simulations, to rationally design next-generation drug compounds and predict their interactions. This path in the DSDD specialisation is ideal for students eager to apply cutting-edge computational techniques to improve drug discovery, enhance drug efficacy, and prevent unwanted side effects, with a strong emphasis on interdisciplinary collaboration in drug design and development.

         Click here for a video on the exciting aspects of computer-aided drug design, with an inside look into the   
         VU modeling laboratories.

    Curriculum
    The study programme of this specialisation consists of compulsory courses (12 ECTS), constrained elective courses (at least 12 ECTS), additional elective modules, and a major research project (48 ECTS), conducted in either an academic, company or institute setting.

    The compulsory courses within the DSDD specialisation cover:

    • Physical Organic Chemistry: focusing on the physical-chemistry concepts that are essential for both understanding and exercising organic synthesis as well as for understanding drug-ligand interaction.
    • Computational Design and Synthesis of Drugs: focusing on the use of molecular modelling and retrosynthetic analysis to discover molecular hits for drug research.

    The compulsory courses are complemented by the selection of at least two out of six constrained electives that are chosen depending on the path taken within this specialisation. The constrained elective courses include:

    • Synthetic Approaches in Medicinal Chemistry: covering the toolbox of synthetic-organic reactions that drug researchers have at their disposal to prepare biologically interesting organic molecules.
    • Computer-Aided Drug Design and Virtual Screening: exploring key concepts in protein homology modelling, chemoinformatics, and structure-based virtual screening, with a focus on ligand discovery, molecular docking, and integrating in silico methods with experimental studies.
    • Spectroscopic Approaches in Medicinal Chemistry: exploring various techniques key in safeguarding the identity and purity of synthesised molecules, with an emphasis on advanced 2D NMR spectroscopy.
    • Data Analysis in Drug Discovery: learning how to efficiently retrieve, manage, and analyse research data from drug discovery using databases and open-source tools, with a focus on automating data tasks, applying advanced analysis techniques (including AI) and developing robust data management plans.
    • Biocatalysis for a Sustainable Future: exploring the use of enzymes to facilitate smart and sustainable organic synthesis, as inspired by the biocatalytic mechanisms in nature.
    • Advanced Radiopharmaceutical Chemistry: learning how to chemically synthesise and use molecules that incorporate short-lived isotopes for use in clinical diagnostics.

    Depending on the interest of the student, courses addressing both paths can be selected as electives to become more interdisciplinary trained within the design and synthesis of drugs.

    In addition to the compulsory courses and constrained electives, students may choose from further electives, such as additional courses, a literature thesis, or a minor research project, enabling them to broaden their profile and strengthen their interdisciplinary training.

    If you have any questions about the curriculum, please visit the Online Master’s Event on 27 November or contact the specialisation coordinator.

    Ideal candidates
    The DSDD specialisation is designed for students with a background in organic and physical chemistry and with a keen interest in understanding and exploring the role of chemistry in drug research, chemical biology, and diagnosis. The following background per path in this specialisation is expected:

    • Synthetic Medicinal Chemistry path: the candidate has a background in organic synthesis and/or synthetic medicinal chemistry, as evidenced by theoretical courses, practical courses and research internship(s).
    • Computer-Aided Drug Design path: the candidate has a background in molecular modelling and/or physical chemistry, as evidenced by theoretical courses, practical courses and research internship(s).

    Learn more about admission requirements.

  • Pharmacology and Toxicology in Drug Discovery

    Summary

    Unravelling the molecular mechanisms behind drug action and their harmful side effects
    The Pharmacology and Toxicology in Drug Discovery (PTDD) specialisation within the Drug Discovery Sciences Master’s programme focuses on the beneficial and adverse effects of drugs on biological systems at the molecular and cellular levels.

    This specialisation offers two complementary paths:

    • Molecular Pharmacology: this path focuses on the intricate mechanisms by which drugs interact with biological systems at the molecular and cellular levels. This track equips students with a profound understanding of receptor pharmacology, signal transduction pathways, and the molecular basis of drug efficacy. Emphasising both theoretical knowledge and practical skills, the programme prepares graduates to contribute to the development of novel therapeutics and the optimization of existing drug therapies.
    • Molecular Toxicology: this path focuses on the in-depth exploration of the cellular stress responses and the molecular mechanisms underlying the toxic effects of pharmaceuticals, as well as food additives, contaminants, environmental pollutants, and industrial chemicals. This track equips students with the knowledge and skills to assess and predict toxicological outcomes, contributing to the development of safer therapeutic agents and protection of public health. By integrating theoretical knowledge with practical experience, the programme prepares graduates to address complex challenges in toxicology and health sciences.

         Click here for a video where VU scientist Anja Wilmes is investigating possibilities to make medicines more
         personal, so that they better match the DNA of your body. 

    Curriculum
    The study programme of this specialisation consists of compulsory courses (12 ECTS), constrained elective courses (at least 12 ECTS), additional elective modules, and a major research project (48 ECTS), conducted in an academic, company or institute setting.

    The compulsory courses within the PTDD specialisation cover:

    • ADME: understanding how absorption, distribution, metabolism, and excretion influence drug efficacy and safety.
    • Drug Target Biochemistry and Signalling: exploring the pathways and networks involved in cellular responses to drugs.

    The compulsory courses are complemented by the selection of at least two out of six constrained electives, selected according to the chosen path. The constrained elective courses include:

    • Advanced pharmacology: focusing on the molecular basis and quantification of drug-target interaction and modulation of cellular responses.
    • Molecular and Cellular Toxicology: understanding of the major stress-response pathways and methods to study the effect of chemicals/drugs on cells.
    • Advanced Bioanalytical Approaches: mastering state-of-the-art techniques for bioanalysis, from sample preparation to data interpretation, in drug discovery, clinical, toxicological, and forensic contexts.
    • Biopharmaceutical and Biopharma Proteomics: understanding the development, characterization, and bioanalytical techniques for biopharmaceuticals, with a focus on monoclonal antibodies, venoms-to-drugs pipelines, and proteomics in drug discovery.
    • Advanced Course in Molecular Toxicology: an in-depth exploration of toxicological principles, mechanisms of toxicity, and current research topics in molecular toxicology.
    • Data Analysis in Drug Discovery: learning how to efficiently retrieve, manage, and analyse research data from drug discovery using databases and open-source tools, with focuses on automating data tasks, applying advanced analysis techniques (including AI) and developing robust data management plans.

    Depending on the student’s interests, courses from both paths can be selected as electives to become interdisciplinarily trained in the field of pharmacology and toxicology.

    If you have any questions about the curriculum, please visit the Online Master’s Event on 27 November or contact the specialisation coordinator.

    Ideal candidates
    This specialisation is designed for students with a BSc or BASc background in medicinal chemistry, biochemistry, pharmacology, molecular biology, cellular biology, or related fields, and a keen interest in understanding the molecular basis of drug actions and/or toxicity. A commitment to scientific research and a passion for innovation in therapeutic discovery and development, and/or improving public health through the study of toxicology are essential qualities for prospective students.

    Learn more about admission requirements.

  • Bioanalytics in Drug Discovery

    Summary

    Unravelling molecular insights in drug discovery
    The Bioanalytics in Drug Discovery (BADD) specialisation within the Master’s programme in Drug Discovery Sciences focuses on advanced analytical techniques central to modern drug discovery and development. Students gain expertise in state-of-the-art methods, including mass spectrometry, chromatography, and nuclear magnetic resonance spectroscopy, to investigate drug candidates, their metabolites, their interactions with protein-based targets, and the molecular mechanisms underpinning therapeutic interventions. This specialisation is designed for students eager to apply cutting-edge bioanalytical tools to improve drug efficacy, deepen their understanding of disease mechanisms, and contribute to the creation of safer, more effective therapies. Students also receive dedicated training in metabolomics and proteomics. With a strong emphasis on practical experience and interdisciplinary collaboration, the programme equips graduates for impactful careers in pharmaceutical research, biotechnology, and any other career avenues involving bioanalytical chemistry expertise.

    Click here for a video about what you can learn during the Bioanalytics specialisation.

    Curriculum
    The study programme of this specialisation consists of compulsory courses (12 ECTS), constrained elective courses (at least 12 ECTS), additional elective modules, and a major research project (48 ECTS), conducted in either an academic, a company or an institute setting in the Netherlands or abroad.

    The compulsory courses within the BADD specialisation cover:

    • Advanced Bioanalytical Approaches: mastering state-of-the-art techniques for bioanalysis, from sample preparation to data interpretation, in drug discovery, clinical, toxicological, and forensic contexts.
    • Biopharmaceuticals & Biopharma Proteomics: understanding the development, characterisation, and bioanalytical techniques for biopharmaceuticals, with a focus on monoclonal antibodies, venoms-to-drugs pipelines, and proteomics in drug discovery.

    The compulsory courses are complemented by the selection of minimally two out of six constrained electives. The constrained elective courses include:

    • ADME: understanding how absorption, distribution, metabolism, and excretion influence drug efficacy and safety.
    • Drug Target Biochemistry and Signalling: exploring the pathways and networks involved in cellular responses to drugs.
    • Spectroscopic Approaches in Medicinal Chemistry: exploring various techniques key to safeguarding the identity and purity of synthesised molecules, with an emphasis on advanced 2D NMR spectroscopy.
    • Separation Sciences: exploring the fundamentals and applications of chromatography and electrophoresis, including topics such as instrumentation, sample preparation, separation performance, gradient elution, two-dimensional gas chromatography, and polymer analysis.
    • Biocatalysis for a Sustainable Future: exploring the use of enzymes to facilitate smart and sustainable organic synthesis, as inspired by the biocatalytic mechanisms in nature.
    • Data Analysis in Drug Discovery: learning how to efficiently retrieve, manage, and analyse research data from drug discovery using databases and open-source tools, with a focus on automating data tasks, applying advanced analysis techniques (including AI) and developing robust data management plans.

    In addition to the compulsory courses and constrained electives, students may choose from further electives, such as additional courses, a literature thesis, or a minor research project, enabling them to broaden their profile and strengthen their interdisciplinary training.

    If you have any questions about the curriculum, please visit the Online Master’s Event on 27 November or contact the specialisation coordinator.

    Ideal candidates
    The BADD specialisation is designed for students with a background in analytical chemistry, as evidenced by theoretical courses, practical courses, and preferably a research internship in the field. They also have a strong interest in applying analytical techniques to investigate drug action and disease mechanisms.

    Learn more about admission requirements.

  • Education in Drug Discovery

    Summary

    From lab to classroom
    The Educational specialisation within the Drug Discovery Sciences Master’s programme is designed for those who want to pursue a teaching career. The programme starts with a first year consisting of courses in drug discovery sciences and a research internship. In the second year, students follow the Dutch teacher training program, which leads to a qualification to teach at secondary and vocational education levels. Please note that the second year of this track is taught in Dutch.

    Curriculum
    The Educational specialisation offers a tightly structured programme: the first year focuses on building subject-specific expertise in drug discovery sciences, while the second year is dedicated to applying this knowledge in teaching practice.

    Year 1: Drug Discovery Sciences

    This year covers:

    • Compulsory DDS courses (12 ECTS):
      • ADME: understanding how absorption, distribution, metabolism, and excretion influence drug efficacy and safety.
      • Computational Design and Synthesis of Drugs: focusing on the use of molecular modelling and retrosynthetic analysis to discover molecular hits for drug research.
    • Elective modules (18 ECTS): within this component, you choose courses based on your interests and the topic of your research internship. We strongly recommend the course Computer-Aided Drug Design and Virtual Screening (6 ECTS). Please note that if you have not completed the bachelor’s programme in Pharmaceutical Sciences at VU, you are required to take two additional Principles courses (12 ECTS) within this component.
    • Research internship (30 ECTS): usually running from February to July. The education major project primarily focused on modelling, dry lab internships and in silico experiments. Contact the specialisation coordinator for more information about possible projects.

    Year 2: Teacher education covers:

    Because of the strict planning, courses from the first year cannot be shifted into the second year. The specialisation coordinator will guide you in planning your first year, while a dedicated education coordinator will support you during the second year.

    For detailed information about the individual courses, please see the Study Guide.

    Ideal candidate
    The Educational specialisation is intended for students with a strong background in (bio)chemistry who are eager to share their knowledge with the next generation. It is the right choice for those who want to combine their expertise in drug discovery sciences with pedagogy and obtain a formal qualification to teach chemistry at Dutch secondary and vocational education level.

Which second year specialisation do you choose?

Find out what the different possibilities are within the second year of this Master's programme

Summary

In the second year, the Research specialisation focuses on advanced topics in Drug Discovery Sciences. This track prepares you for a research career, whether in academia (e.g., a PhD) or the pharmaceutical industry. You’ll conduct a major research project, gaining hands-on experience in cutting-edge science. Additionally, you’ll have the flexibility to choose elective courses from the Drug Discovery and Safety Master’s programme – or use that space to pursue a second research internship, possibly abroad.

Visit the Study guide for course descriptions and the year schedule. 

  • Research

    Summary

    In the second year, the Research specialisation focuses on advanced topics in Drug Discovery Sciences. This track prepares you for a research career, whether in academia (e.g., a PhD) or the pharmaceutical industry. You’ll conduct a major research project, gaining hands-on experience in cutting-edge science. Additionally, you’ll have the flexibility to choose elective courses from the Drug Discovery and Safety Master’s programme – or use that space to pursue a second research internship, possibly abroad.

    Visit the Study guide for course descriptions and the year schedule. 

Internships

You will conduct your major internship in one of the internationally renowned research groups within the Department of Chemistry and Pharmaceutical Sciences at VU Amsterdam, or elsewhere in the Netherlands or abroad at either an (academic) institute or a company. If you conduct your internship at the VU, a PhD student or a postdoctoral researcher will supervise you, and you will be part of a research group, including work discussions and colloquiums.

If you choose any of the three Research specialisations, you have the option to conduct a second internship at, for instance, a company or an academic institution. Just as with the major internship, this can be performed in the Netherlands or abroad. You can arrange research internships relatively easily through ULLA, the European Consortium for training in the Pharmaceutical Sciences. The consortium has grants available for Master’s students from ULLA member institutions who perform internships at ULLA partner institutions. The Master’s coordinators and other staff members from the Department of Chemistry and Pharmaceutical Sciences can also help you find an opportunity to study abroad, either within the academic world or in the pharmaceutical industry.

Change your future with the Drug Discovery Sciences programme

Change your future with the Drug Discovery Sciences programme

After completing this Master’s programme, you can choose to enter the job market or join a PhD programme. As a graduate in Drug Discovery Sciences, you can start work as a medicinal chemist, as a product manager at a pharmaceutical company, or as a researcher at a hospital laboratory. There are also plenty of opportunities within research institutes and governmental agencies.

Explore your future prospects
Researchers in a lab

Want to know more?

For questions regarding this Master's programme, please send an email to: DDS.beta@vu.nl.

Quick links

Homepage Culture on campus VU Sports Centre Dashboard

Study

Academic calendar Study guide Timetable Canvas

Featured

VUfonds VU Magazine Ad Valvas Digital accessibility

About VU

Contact us Working at VU Amsterdam Faculties Divisions
Privacy Disclaimer Safety Web Colophon Cookie Settings Web Archive

Copyright © 2025 - Vrije Universiteit Amsterdam